A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...

Combining the test with assessment of the CA 19-9 cancer biomarker increased the sensitivity to 85% with a specificity of 96%. The protease-activated test showed potential for detecting pancreatic ...

with the company saying that the test was significantly more accurate than CA19-9, the biomarker commonly used to detect pancreatic cancer. Additionally, Immunovia has said that its new test opens ...